LATEST NEWS
Keeping an "Eye on Innovation" Through News & Analysis
Takeaway from FDA Imaging Forum: Need for Consensus Standards for Optical Coherence Tomography
Continued advances in optical coherence tomography are generating excitement for more precise and earlier diagnosis of eye disease, but more research and industry agreement on ...
Will Dexycu’s Cost Inhibit Its Use?
Eric Donnenfeld, MD, of Ophthalmic Consultants of Long Island, recently performed the first cataract surgery in the country using Dexycu (EyePoint Pharmaceuticals), administered as a ...
OIS Index Delivers Stellar First-Quarter 2019 Performance
The OIS Index of ophthalmic stocks solidly outperformed its market benchmarks in the first quarter of 2019, gaining 37.1%. During Q1, the overall US stock ...
Dr. Mark Blumenkranz Previews Panel on OCT Imaging and Forum on Laser-Based Imaging
Regulatory and reimbursement issues surrounding laser-based imaging modalities such as optical coherence tomography and adaptive optics, as well as the emerging role of artificial intelligence ...
Will a New Drug Using Cannabinoids Achieve a Breakthrough for Glaucoma?
SAN FRANCISCO – Nemus Bioscience, a biopharmaceutical company based in Southern California, came to the Glaucoma 360 New Horizons Forum here in February to make ...
Biogen Jumps Back into Ophthalmology Gene Therapy with Nightstar Acquisition
It didn’t take Biogen long to jump back into ophthalmology after announcing its intention in December 2018 to terminate a collaborative agreement with Applied Genetic ...
LATEST PODCASTS
Candid Conversations With Ophthalmology's Innovators & Business Leaders
TESTIMONIALS
Why People Attend OIS
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.